Raia Drogasil S.A.
RADLY
$3.62
-$0.07-1.90%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 18.16% | 8.03% | -0.14% | -3.50% | -2.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.16% | 8.03% | -0.14% | -3.50% | -2.16% |
| Cost of Revenue | 17.98% | 8.11% | -0.01% | -3.46% | -2.18% |
| Gross Profit | 18.57% | 7.83% | -0.46% | -3.60% | -2.11% |
| SG&A Expenses | 16.37% | 7.60% | 0.32% | -3.35% | -1.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1,314.56% | -374.82% | 67.96% | 81.09% | 87.71% |
| Total Operating Expenses | 18.19% | 7.89% | 0.21% | -3.17% | -1.72% |
| Operating Income | 17.70% | 10.09% | -5.39% | -8.52% | -8.65% |
| Income Before Tax | 6.38% | -3.47% | -10.31% | -12.12% | -10.04% |
| Income Tax Expenses | -39.22% | -40.15% | -81.24% | -69.40% | -35.81% |
| Earnings from Continuing Operations | 12.37% | 3.26% | 7.81% | -0.14% | -5.03% |
| Earnings from Discontinued Operations | -42.70% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 74.55% | 76.52% | 44.71% | 57.81% | 79.96% |
| Net Income | 11.89% | 5.82% | 11.04% | 3.37% | -0.92% |
| EBIT | 17.70% | 10.09% | -5.39% | -8.52% | -8.65% |
| EBITDA | 19.11% | 11.42% | -4.16% | -7.13% | -7.68% |
| EPS Basic | 31.20% | 23.03% | 28.36% | 20.85% | -11.68% |
| Normalized Basic EPS | 20.34% | 12.60% | -1.59% | 1.08% | -20.04% |
| EPS Diluted | 30.47% | 22.87% | 28.31% | 20.72% | -11.71% |
| Normalized Diluted EPS | 19.45% | 12.41% | -1.71% | 0.96% | -19.98% |
| Average Basic Shares Outstanding | -17.72% | -17.35% | -16.38% | -16.78% | 16.12% |
| Average Diluted Shares Outstanding | -17.00% | -17.22% | -16.30% | -16.63% | 16.06% |
| Dividend Per Share | 73.10% | 211.45% | -38.79% | 13.10% | -36.43% |
| Payout Ratio | 0.23% | 0.30% | -0.09% | -0.02% | -0.08% |